Related Experiment Video
Updated: May 16, 2026

Detecting the Ligand-binding Domain Dimerization Activity of Estrogen Receptor Alpha Using the Mammalian Two-Hybrid Assay
Published on: December 19, 2018
Cooperating transcription factors mediate the function of estrogen receptor
Elisa Fiorito1, Madhumohan R Katika, Antoni Hurtado
1Breast Cancer Research group, Centre for Molecular Medicine Norway, Nordic EMBL Partnership, University of Oslo and Oslo University Hospital, 0318 Oslo, Norway.
Abstract:
Estrogen receptor (ER) is a hormone-regulated transcription factor that controls cell division and differentiation in the ovary, breast, and uterus. The expression of ER is a common feature of the majority of breast cancers, which is used as a therapeutic target. Recent genetic studies have shown that ER binding occurs in regions distant to the promoters of estrogen target genes. These studies have also demonstrated that ER binding is accompanied with the binding of other transcription factors, which regulate the function of ER and response to anti-estrogen therapies. In this review, we explain how these factors influence the interaction of ER to chromatin and their cooperation for ER transcriptional activity. Moreover, we describe how the expression of these factors dictates the response to anti-estrogen therapies. Finally, we discuss how cytoplasmatic signaling pathways may modulate the function of ER and its cooperating transcription factors.
Insights
Estrogen receptor (ER) binding to DNA involves other transcription factors, influencing gene activity and response to anti-estrogen therapies in breast cancer treatment. Understanding these interactions is key for targeted therapies.
Area of Science:
- Endocrinology and Molecular Biology
- Cancer Research
- Genetics
Background:
- Estrogen receptor (ER) is a key transcription factor regulating cell growth in reproductive tissues.
- ER expression is prevalent in most breast cancers, making it a critical therapeutic target.
- Emerging research reveals ER binding occurs at distant gene regions, not just promoters.
Purpose of the Study:
- To review how transcription factors cooperate with ER for transcriptional activity.
- To explain how ER-associated factors influence chromatin interaction.
- To discuss the role of these factors and cytoplasmic pathways in anti-estrogen therapy response.
Main Methods:
- Literature review of genetic studies on ER binding and transcription factor cooperation.
- Analysis of mechanisms influencing ER-chromatin interactions.
- Discussion of signaling pathways modulating ER function.
Main Results:
- ER binding is often distant from gene promoters and involves co-factors.
- Co-transcription factors modulate ER's interaction with chromatin.
- The expression of these factors is critical for predicting response to anti-estrogen therapies.
Conclusions:
- Co-transcription factors and cytoplasmic pathways significantly impact ER function and therapeutic outcomes.
- Targeting ER and its cooperating factors offers potential for improved breast cancer treatment.
- Further research into these complex interactions is warranted for personalized medicine.
Related Concept Videos
Co-activators and Co-repressors
Co-activators and Co-repressors
Transducer Mechanism: Nuclear Receptors
About 48 different soluble family members of nuclear receptors are identified that can be divided into two main classes:
RNA Polymerase II Accessory Proteins
Transcription Factors
Transcription Factors

